TITLE

Tiotropium for Uncontrolled Asthma

PUB. DATE
December 2010
SOURCE
Internal Medicine Alert;12/15/2010 Clinical Briefs, p1
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports on the findings of a study that suggest that tiotropium, a long-acting anticholinergic inhaler, has been approved for the treatment of chronic obstructive pulmonary disease.
ACCESSION #
57803282

 

Related Articles

  • Tiotropium for uncontrolled asthma.  // Neurology Alert;Dec2010 Supplement, p1 

    The article focuses on a study which investigated the therapeutic use of tiotropium, a long-acting anticholinergic inhaler, for patients with chronic obstructive pulmonary disease (COPD).

  • New treatment for COPD launched.  // Pulse;9/9/2002, Vol. 62 Issue 34, p4 

    Announces the launch of Spiriva, an anticholinergic bronchodilator for the treatment of chronic obstructive pulmonary disease by Boehringer Ingelheim and Pfizer in Great Britain.

  • Safety of Inhaled Anticholinergics for COPD Scrutinized. Elliott, William T. // Critical Care Alert;Nov2008 Pharmacology Watch, p1 

    The article focuses on the safety of inhaled anticholinergics for the treatment of chronic obstructive pulmonary disease (COPD).

  • Tiotropium cost effective in COPD in UK and Belgium.  // PharmacoEconomics & Outcomes News;11/10/2012, Issue 666, p7 

    The article discusses research on adding tiotropium to standard care that references the study "Cost-utility analysis of tiotropium versus usual care in patients with chronic obstructive pulmonary disease (COPD) in the U.K. and Belgium," by R. Hettle et al in the October 2012 issue of...

  • COMMENTARY. Niewoehner, Dennis E. // Evidence Based Medicine;May2003, p74 

    The author discusses aspects of drug effectiveness wherein he recommends that an anticholinergic agent can be combined with beta blocker agonist in the treatment pf patients with chronic obstructive pulmonary disease (COPD).

  • Review: anticholinergics in addition to β2 agonists improve outcome in children and adults with acute asthma. Rodrigo, G. J.; Castro-Rodriguez, J. A. // Evidence Based Medicine;Feb2006, Vol. 11 Issue 1, p21 

    The article reports on a study which reviews various research to determine whether inhaled anticholinergic agents plus β2 agonists can enhanced outcome in children and adults with acute asthma exacerbations compared to β2 agonists alone. The studies examined used randomized controlled...

  • Commentary. Thien, Frank // Evidence Based Medicine;Feb2006, Vol. 11 Issue 1, p21 

    The article comments on a study by G. J. Rodrigo and colleagues which reviews various research to determine whether inhaled anticholinergic agents plus β2 agonists can enhanced outcome in children and adults with acute asthma exacerbations compared to β2 agonists alone. The meta-analysis...

  • Tiotropium improves lung function and reduces COPD exacerbations. Mayor, Susan // British Journal of Hospital Medicine (17508460);Nov2008, Vol. 69 Issue 11, p614 

    The article reports on the study from Understanding Potential Long-term Impacts on Function with Tiotropium (UPLIFT). After 4-year global trial in chronic obstructive pulmonary disease (COPD), UPLIFT is evaluating the potential of the drug to slow disease progression by reducing the rate of...

  • Safety of Inhaled Anticholinergics for COPD Scrutinized. Elliott, William T. // Primary Care Reports;Nov2008 Pharmacology Watch, p1 

    The article considers the safety of inhaled anticholinergics for the treatment of chronic obstructive pulmonary disease (COPD), which was prompted by a communication from the U.S. Food and Drug Administration (FDA) regarding the safety review of tiotropium. Two studies linking inhaled...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics